Insights from the ADVOCATE Study: Respiratory Tract Involvement in Patients with ANCA-Associated Vasculitis in a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Avacopan

被引：0
|
作者：
Specks, U. [1 ]
Jayne, D. R. W. [2 ]
Merkel, P. A. [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Cambridge, Cambridge, England
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4780
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia
    Kuriakose, Moni Abraham
    Ramdas, Kunnambath
    Dey, Bindu
    Iyer, Subramanya
    Rajan, Gunaseelan
    Elango, Kalavathy K.
    Suresh, Amritha
    Ravindran, Divya
    Kumar, Rajneesh R.
    Prathiba, R.
    Ramachandran, Surya
    Kumar, Nisha Asok
    Thomas, Gigi
    Somanathan, Thara
    Ravindran, Hiran K.
    Ranganathan, Kannan
    Katakam, Sudhakar Babu
    Parashuram, Shivashankar
    Jayaprakash, Vijayvel
    Pillai, M. Radhakrishna
    CANCER PREVENTION RESEARCH, 2016, 9 (08) : 683 - 691
  • [32] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
    Butchart, Joseph
    Brook, Laura
    Hopkins, Vivienne
    Teeling, Jessica
    Puentener, Ursula
    Culliford, David
    Sharples, Richard
    Sharif, Saif
    McFarlane, Brady
    Raybould, Rachel
    Thomas, Rhodri
    Passmore, Peter
    Perry, V. Hugh
    Holmes, Clive
    NEUROLOGY, 2015, 84 (21) : 2161 - 2168
  • [33] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [34] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
    Tufan, Ayse N.
    Tufan, Fatih
    NEUROLOGY, 2015, 85 (23) : 2083 - 2084
  • [35] A multicenter, randomized, double-blind, placebo-controlled trial of valproate for agitation associated with dementia
    Tariot, PN
    Thal, L
    Jakimovich, L
    Thomas, R
    Raman, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S189 - S189
  • [36] Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial
    Geetha, Duvuru
    Pagnoux, Christian
    Sattui, Sebastian E.
    Merkel, Peter A.
    Weiner, Maria
    Draibe, Juliana
    Faguer, Stanislas
    Bray, Sarah
    Gurlin, Rachel E.
    Balcells-Oliver, Monica
    Bruchfeld, Annette
    Jayne, David R.
    ADVOCATE Study Grp, C.
    RHEUMATOLOGY, 2025,
  • [37] A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
    Harrison, Stephen A.
    Ruane, Peter J.
    Freilich, Bradley
    Neff, Guy
    Patil, Rashmee
    Behling, Cynthia
    Hu, Chen
    Shringarpure, Reshma
    de Temple, Brittany
    Fong, Erica
    Tillman, Erik J.
    Rolph, Timothy
    Cheng, Andrew
    Yale, Kitty
    JHEP REPORTS, 2023, 5 (01)
  • [38] A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
    Cui, Chuanliang
    Mao, Lili
    Chi, Zhihong
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Li, Siming
    Lian, Bin
    Gu, Kangsheng
    Tao, Min
    Song, Xin
    Lin, Tongyu
    Ren, Xiubao
    Qin, Shukui
    Guo, Jun
    MOLECULAR THERAPY, 2013, 21 (07) : 1456 - 1463
  • [39] A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
    Lynch, David R.
    Perlman, Susan L.
    Meier, Thomas
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 941 - 947
  • [40] Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
    Stephen A. Harrison
    Rebecca Taub
    Guy W. Neff
    K. Jean Lucas
    Dominic Labriola
    Sam E. Moussa
    Naim Alkhouri
    Mustafa R. Bashir
    Nature Medicine, 2023, 29 : 2919 - 2928
12345